SCHEDULE 13G/A: BlackRock Discloses 13.8% Stake in Lemaitre Vascular Inc. Through Latest SEC Filing

BlackRock, Inc. has filed an Amendment No. 4 to Schedule 13G, reporting a beneficial ownership of 13.8% of Lemaitre Vascular Inc.'s common stock as of March 31, 2025.

Summary

• BlackRock, Inc. reported beneficial ownership of 3,102,917 shares of Lemaitre Vascular Inc. common stock.
• This represents 13.8% of the total outstanding common stock of Lemaitre Vascular Inc.
• BlackRock holds sole voting power over 3,080,296 shares and sole dispositive power over 3,102,917 shares.
• The filing is an Amendment No. 4 to Schedule 13G, indicating an update to a previously reported stake.
• One of BlackRock's subsidiaries, iShares Core S&P Small-Cap ETF, is noted as having an interest of more than five percent of the total outstanding common stock of Lemaitre Vascular Inc.

Sentiment

Score: 5

Explanation: The document is a factual disclosure of beneficial ownership and does not contain subjective or forward-looking statements that would indicate a positive or negative sentiment regarding the issuer's performance or outlook.

Positives

• The disclosure of a significant stake by a major institutional investor like BlackRock could be viewed as a vote of confidence in Lemaitre Vascular Inc. by some investors.

Negatives

• The document, being a Schedule 13G filing, primarily discloses beneficial ownership and does not contain information typically categorized as negative operational or financial news for the issuer.

Risks

• The document does not detail specific risks for Lemaitre Vascular Inc.

Future Outlook

NA

Management Comments

• "The securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under 240.14a-11."

Industry Context

NA

Stakeholder Impact

• Shareholders: The disclosure of a significant stake by a major institutional investor like BlackRock may be viewed positively, indicating institutional confidence in Lemaitre Vascular Inc.

Key Dates

Keywords

BlackRock, Lemaitre Vascular Inc., Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, SEC Filing, Investment Management, Vascular Devices